<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45215">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01894126</url>
  </required_header>
  <id_info>
    <org_study_id>K12HD001264-14UNGER</org_study_id>
    <nct_id>NCT01894126</nct_id>
  </id_info>
  <brief_title>Mobile Phone Messaging to Improve Women's and Children's Health (Mobile WACh) in Kenya</brief_title>
  <acronym>Mobile WACh</acronym>
  <official_title>Mobile Phone One Way Short Message Service (SMS) Versus SMS Dialogue for Women's and Child Health (Mobile WaCH) in Kenya: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Nairobi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kenyatta National Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>Kenya: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the increased prevalence of cellular phones, mobile technology provides an important
      tool to reach underserved populations in low to middle income countries. mHealth
      interventions offer promise to improve maternal child health throughout the reproductive
      health continuum if they contribute to increasing skilled birth attendance, family planning
      and exclusive breastfeeding.  We propose a randomized clinical trial to determine effect of
      using mobile phones to deliver SMS (one-way) versus an interactive SMS dialogue (two-way) on
      uptake of reproductive and neonatal health services and maternal and infant outcomes
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Contraceptive uptake</measure>
    <time_frame>10 weeks postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Facility Delivery</measure>
    <time_frame>Postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>ANC attendance</measure>
    <time_frame>Postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exclusive Breastfeeding</measure>
    <time_frame>Six months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant Immunizations</measure>
    <time_frame>Six months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal morbidity</measure>
    <time_frame>6 months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant morbidity</measure>
    <time_frame>Six months postpartum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Maternal Health</condition>
  <condition>Neonatal Health</condition>
  <condition>Family Planning</condition>
  <arm_group>
    <arm_group_label>Two-way SMS dialogue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women will receive SMS messages with prompts to reply.  They will have the ability to text back to the system and both respond to and initiate SMS dialogue</description>
  </arm_group>
  <arm_group>
    <arm_group_label>One-way SMS Messaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women will receive scheduled one-way SMS messages</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Two-way SMS Dialogue</intervention_name>
    <arm_group_label>Two-way SMS dialogue</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>One-way SMS Messaging</intervention_name>
    <arm_group_label>One-way SMS Messaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant

          -  Access to a mobile phone

          -  Able to read SMS messages

          -  Willing to receive SMS messages

        Exclusion Criteria:

          -  Unwilling or unable to meet inclusion criteria
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jennifer Unger, MD, MPH</last_name>
    <email>junger@uw.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dyphna Mogaka</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mathare North Health Centre</name>
      <address>
        <city>Nairobi</city>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dyphna Mogaka</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 8, 2013</lastchanged_date>
  <firstreceived_date>July 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Jennifer Unger</investigator_full_name>
    <investigator_title>Acting Assistant Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
